SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-046986
Filing Date
2023-04-19
Accepted
2023-04-19 08:09:00
Documents
2
Period of Report
2023-04-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2313135-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2313135-1_3seq1.xml 3 17447
2 EXHIBIT 24 tm2313135d1_ex24.htm EX-24 7968
  Complete submission text file 0001104659-23-046986.txt   26922
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ASTRIA THERAPEUTICS, INC. 75 STATE STREET, SUITE 1400 BOSTON MA 02109
Business Address
Matthews Andrea (Reporting) CIK: 0001973349 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37467 | Film No.: 23828506